FindTrial
Sign In

Clinical trial on efficacy and safety of eradication therapy for Helicobacter pylori infection to prevent gastric cancer.

Clinical trial on efficacy and safety of eradication therapy for Helicobacter pylori infection to prevent gastric cancer. - Helicobacter eradication for gastric cancer prevention.

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001434
Enrollment
1600
Registered
2008-10-20
Start date
2008-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrophic gastritis with H. pylori infection

Interventions

Eradication therapy for H. pylori infection

Sponsors

Department of Gastroenterology University of Tokyo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. positive for H. pylroi infection 2. atrophic gastritis by endoscopy

Exclusion criteria

Exclusion criteria: 1. gastric malignancies or gastric adenomas 2. gastroduodenal ulcers 3. allergy for medicine used in this study

Design outcomes

Primary

MeasureTime frame
Gastirc cancer diagnosed by endoscopy—

Secondary

MeasureTime frame
safety—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026